We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+18.4%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$1.28B
AUM Growth
+$253M
Cap. Flow
+$143M
Cap. Flow %
11.17%
Top 10 Hldgs %
13.47%
Holding
1,446
New
471
Increased
321
Reduced
302
Closed
327

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$16.8M
2
U icon
Unity
U
+$14M
3
AIFC
AI Financial Corp
AIFC
+$13.8M
4
CYBR
CyberArk
CYBR
+$12.6M
5
NSC icon
Norfolk Southern
NSC
+$11.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$13.2M
2
TSLA icon
Tesla
TSLA
+$12.9M
3
BIDU icon
Baidu
BIDU
+$11.9M
4
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$10M
5
AMED
Amedisys
AMED
+$8.89M

Sector Composition

Rank Sector Weight
1 Technology 21.32%
2 Communication Services 11.38%
3 Healthcare 11.08%
4 Consumer Discretionary 10.37%
5 Financials 9.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
751
BioMarin Pharmaceuticals
BMRN
$13.6B
$288K 0.02%
+5,317
New +$304K
HII icon
752
Huntington Ingalls Industries
HII
$13.1B
$288K 0.02%
1,000
-1,000
-50% -$266K
SB icon
753
Safe Bulkers
SB
$747M
$288K 0.02%
+64,793
New +$275K
MELI icon
754
Mercado Libre
MELI
$96.1B
$287K 0.02%
123
-1,805
-94% -$4.33M
IRTC icon
755
iRhythm Holdings
IRTC
$4.01B
$287K 0.02%
+1,671
New +$266K
HAYW icon
756
Hayward Holdings
HAYW
$3.31B
$287K 0.02%
+18,998
New +$291K
SPY icon
757
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$811B
$287K 0.02%
845
+303
+56% +$194K
XEL icon
758
Xcel Energy
XEL
$48.1B
$286K 0.02%
3,552
-637
-15% -$46.1K
VCLT icon
759
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.76B
$286K 0.02%
+3,680
New +$280K
AGO icon
760
Assured Guaranty
AGO
$3.33B
$284K 0.02%
3,357
+199
+6% +$16.5K
TACO
761
Berto Acquisition Corp
TACO
$392M
$283K 0.02%
+27,215
New +$282K
COST icon
762
Costco
COST
$420B
$282K 0.02%
305
-105
-26% -$101K
DOCN icon
763
DigitalOcean
DOCN
$15B
$281K 0.02%
+8,238
New +$261K
EWC icon
764
iShares MSCI Canada ETF
EWC
$6.51B
$281K 0.02%
+5,563
New +$267K
HSAI
765
Hesai Group
HSAI
$2.99B
$281K 0.02%
10,000
-780
-7% -$19.1K
AVAH icon
766
Aveanna Healthcare
AVAH
$2.06B
$280K 0.02%
31,621
+4,385
+16% +$27.7K
PARR icon
767
Par Pacific Holdings
PARR
$3.65B
$280K 0.02%
+7,897
New +$257K
ADPT icon
768
Adaptive Biotechnologies
ADPT
$4.09B
$279K 0.02%
+18,636
New +$227K
OVV icon
769
Ovintiv
OVV
$17.5B
$278K 0.02%
6,878
-2,846
-29% -$116K
TBLA icon
770
Taboola.com
TBLA
$1.11B
$278K 0.02%
81,400
+28,600
+54% +$97.9K
ITT icon
771
ITT
ITT
$19.4B
$276K 0.02%
+1,546
New +$259K
ACMR icon
772
ACM Research
ACMR
$5.57B
$276K 0.02%
+7,056
New +$209K
HQY icon
773
HealthEquity
HQY
$8.94B
$275K 0.02%
+2,903
New +$273K
BIVI icon
774
BioVie
BIVI
$8.52M
$275K 0.02%
+144,762
New +$586K
LUNR icon
775
Intuitive Machines
LUNR
$2.52B
$274K 0.02%
26,083
+12,127
+87% +$123K
29 30
31
32 33

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return

Prelude Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, Prelude Capital Management held 1,446 positions worth $1.28B, up 25% from $1.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Prelude Capital Management deployed $143M of net new capital in Q3 2025, opening 471 new positions and adding to 321 existing holdings. Its largest new stake was Verona Pharma: 160,565 shares worth $17.1M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $13.2M trimmed.

  • Prelude Capital Management's largest Q3 2025 buy was Verona Pharma: 160,565 shares worth $17.1M.
  • Prelude Capital Management added most to Amazon in Q3 2025, an estimated $11.4M increase.
  • Prelude Capital Management's biggest Q3 2025 reduction was Meta Platforms (Facebook), cutting an estimated $13.2M.
  • Prelude Capital Management fully exited Amedisys in Q3 2025, selling an estimated $8.89M.
  • Prelude Capital Management's ten largest holdings make up 13% of its $1.28B portfolio in Q3 2025.
  • Prelude Capital Management opened 471 new positions and closed 327 in Q3 2025.
  • Prelude Capital Management's portfolio value rose 25% quarter-over-quarter to $1.28B.

Based on Prelude Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.